Division of Digestive Surgery, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
Unit of Surgical Research, University of Geneva, Rue Michel-Servet 1, 1206 Geneva, Switzerland.
Cells. 2020 May 25;9(5):1311. doi: 10.3390/cells9051311.
The roles and interactions of platelets and liver sinusoidal endothelial cells in liver regeneration are unclear, and the trigger that initiates hepatocyte proliferation is unknown. We aimed to identify the key factors released by activated platelets that induce liver sinusoidal endothelial cells to produce interleukin-6 (IL-6), a cytokine implicated in the early phase of liver regeneration. We characterized the releasate of activated platelets inducing the in vitro production of IL-6 by mouse liver sinusoidal endothelial cells and observed that the stimulating factor was a thermolabile protein. Following gel filtration, a single fraction of activated platelet releasate induced a maximal IL-6 secretion by liver sinusoidal endothelial cells (90.2 ± 13.9 versus control with buffer, 9.0 ± 0.8 pg/mL, < 0.05). Mass spectroscopy analysis of this fraction, followed by in silico processing, resulted in a reduced list of 18 candidates. Several proteins from the list were tested, and only recombinant transforming growth factor β1 (TGF-β1) resulted in an increased IL-6 production up to 242.7 ± 30.5 pg/mL, which was comparable to non-fractionated platelet releasate effect. Using neutralizing anti-TGF-β1 antibody or a TGF-β1 receptor inhibitor, IL-6 production by liver sinusoidal endothelial cells was dramatically reduced. These results support a role of platelet TGF-β1 β1 in the priming phase of liver regeneration.
血小板和肝窦内皮细胞在肝再生中的作用和相互作用尚不清楚,触发肝细胞增殖的触发因素也未知。我们旨在确定激活血小板释放的关键因子,这些因子可诱导肝窦内皮细胞产生白细胞介素-6(IL-6),白细胞介素-6 是肝再生早期阶段涉及的细胞因子。我们描述了激活血小板诱导体外产生 IL-6 的小鼠肝窦内皮细胞的释放物的特征,并观察到刺激因子是一种热不稳定的蛋白质。凝胶过滤后,激活血小板释放物的单一级分可诱导肝窦内皮细胞最大程度地分泌 IL-6(90.2±13.9 与缓冲液对照相比,9.0±0.8 pg/mL,<0.05)。对该级分进行质谱分析,然后进行计算机处理,得到一个候选蛋白质列表,减少到 18 个。对该列表中的几种蛋白质进行了测试,只有重组转化生长因子-β1(TGF-β1)可使 IL-6 产生增加到 242.7±30.5 pg/mL,与未分级的血小板释放物效果相当。使用中和抗-TGF-β1 抗体或 TGF-β1 受体抑制剂,肝窦内皮细胞的 IL-6 产生显著减少。这些结果支持血小板 TGF-β1 在肝再生的启动阶段的作用。